CardioComm Solutions, Inc. and GE Healthcare Extend Successful OEM Agreement for Three Years

CardioComm Solutions, Inc., a leading provider of innovative hardware and software solutions for cardiovascular health management, announced the extension of its current OEM agreement with GE Healthcare. The agreement renewal means both companies will continue to play a role in the expanding cardiovascular monitoring and diagnostic devices segment, forecast recently by MarketResearch.com to grow at a CAGR (Compound Annual Growth Rate) of 5% between now and 2017. Approximately three years ago, CardioComm Solutions revealed plans to ship its Global ECG Management System (GEMS) software as part of a multiyear North American licensing, and subsequent OEM, agreement with GE Healthcare. Since then, GE has rebranded CardioComm’s GEMS as GE's noninvasive arrhythmia analysis and diagnostic data management systems, called MARS® Event Station and MARS Event Station Lite. The collaboration has been beneficial for both companies as the new systems provide a high level of flexibility and stability to the cardiac arrhythmia management environment. Etienne Grima, CardioComm Solutions CEO, said, “Our collaboration with GE began in the fall of 2008 and initial sales in ‘09. Our GEMS software proved to be highly compatible with GE hardware and with the majority of loop recorders in the marketplace. We’re proud to say that the MARS Event products have been well received and continue to provide customers with both reliability and ease of use. Consequently GE has chosen to extend our agreement and their financial commitment with us for another three years.” Derek Wagner, Chief Marketing Officer of Patient Care Solutions, GE Healthcare, added, “We are committed to providing our customers with continued and improved Ambulatory ECG Event management solutions. CardioComm has been a preferred supplier of these solutions, and we look forward to continuing our collaboration.” More Information GEMS provides a server-based cardiac arrhythmia management solution for both large cardiology practices and in-hospital use. It is the base system for both transtelephonic 12-lead and arrhythmia monitoring, as well as wireless and soon MTC cardiac monitoring. About CardioComm Solutions, Inc. CardioComm’s patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The company has earned the ISO 13485 certification, is HPB and FDA approved, and HIPAA compliant. CardioComm Solutions, Inc. is headquartered in Toronto, Canada, with offices in Victoria, B.C. About GE Healthcare GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Their broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services helps customers deliver better care to more people around the world at a lower cost. In addition, the company partners with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. GE Healthcare’s “healthymagination” vision for the future invites the world to join them on their journey as they continuously develop innovations focused on reducing costs, increasing access and improving quality around the world.